In the present study, we demonstrated that abnormal elevation of AF6 accelerates the progression of necroptosis and is tightly associated with hepatocyte death and lethal liver pathology, including acute liver injury, NASH and SIRS. This evidence concerns the gene AFDN and metabolic dysfunction-associated steatohepatitis.